GLA and Fabry disease: The accumulation of Gb3 is prominent in GLA‐mutant kidney organoids, which was decreased treated after recombinant enzyme replacement therapy (ERT) with agalsidase‐α (Figure 7d,e), These findings indicate that GLA‐mutant kidney organoids efficiently recapitulate Fabry disease.